Answer
Lenvatinib should be used during pregnancy only if clearly necessary and after careful consideration of the mother's needs and risk to the foetus; there are no data in pregnant women, and lenvatinib was embryotoxic and teratogenic in rats and rabbits.
Sources for this answer
- Lenvatinib Eisai 4mg hard capsulesEisai Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 32Document updated
Sources checked